Refining the orthotopic dog prostate cancer (DPC)-1 model to better bridge the gap between rodents and men

Prostate

Volumn 72, Issue 7, 2012, Pages 752-761

  Anidjar, Maurice ^a   Scarlata, Eleonora ^a   Cury, Fabio L ^a   Rocha, Joice ^a   Hamel, Lucie ^a   Luz, Murilo ^a   Chevalier, Simone ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

animal model; bone metastases; immune suppression; prostate cancer in dog

Indexed keywords

CYCLOSPORIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; BONE METASTASIS; CANCER GROWTH; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIGITAL RECTAL EXAMINATION; FOLLOW UP; HISTOPATHOLOGY; ILIOSACRAL LYMPH NODE; IMMUNOSUPPRESSIVE TREATMENT; IMPLANTATION; LUNG NODULE; LYMPH NODE; LYMPH NODE METASTASIS; MALE; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; PELVIC GIRDLE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; TUMOR VOLUME; ULTRASOUND PROSTATE IMAGING;

ANIMALS; BONE NEOPLASMS; CARCINOMA; CELL LINE, TUMOR; CYCLOSPORINE; DISEASE MODELS, ANIMAL; DOGS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS;

EID: 84860319092     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21479     Document Type: Article

References (23)

1. Siegel R, Ward E, Brawley O, Jemal A, Cancer statistics, 2011. The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61 (4): 212-236.
2. Abdulla A, Kapoor A,. Emerging novel therapies in the treatment of castrate-resistant prostate cancer. Can Urol Assoc J 2011; 5 (2): 120-133.
3. Singh AS, Figg WD,. In vivo models of prostate cancer metastasis to bone. J Urol 2005; 174 (3): 820-826. (Pubitemid 41140603)
4. Moore RA,. Benign hypertrophy and carcinoma of the prostate. Surgery 1944; 16: 152-167.
5. Waters DJ, Sakr WA, Hayden DW, Lang CM, McKinney L, Murphy GP, Radinsky R, Ramoner R, Richardson RC, Tindall DJ,. Workgroup 4: Spontaneous prostate carcinoma in dogs and nonhuman primates. Prostate 1998; 36 (1): 64-67. (Pubitemid 28285643)
6. Root-Kustritz MV, Kausner JS,. Prostatic diseases. In, Ettinger SJ, Feldman EC, editors Textbook of Veterinary Internal Medicine. Diseases of the dog and cat. 5th Edition, Philadelphia, PA: Elsevier Health Sciences; 2000. pp 1687-1698.
7. Cornell KK, Bostwick DG, Cooley DM, Hall G, Harvey HJ, Hendrick MJ, Pauli BU, Render JA, Stoica G, Sweet DC, Waters DJ,. Clinical and pathologic aspects of spontaneous canine prostate carcinoma: A retrospective analysis of 76 cases. Prostate 2000; 45 (2): 173-183.
8. Lai CL, van den Ham R, van Leenders G, van der Lugt J, Mol JA, Teske E,. Histopathological and immunohistochemical characterization of canine prostate cancer. Prostate 2008; 68 (5): 477-488. (Pubitemid 351500208)
9. Eaton CL, Pierrepoint CG,. Growth of a spontaneous canine prostatic adenocarcinoma in vivo and in vitro: Isolation and characterization of a neoplastic prostatic epithelial cell line, CPA 1. Prostate 1988; 12 (2): 129-143.
10. Anidjar M, Villette JM, Devauchelle P, Delisle F, Cotard JP, Billotey C, Cochand-Priollet B, Copin H, Barnoux M, Triballeau S, Rain JD, Fiet J, Teillac P, Berthon P, Cussenot O,. In vivo model mimicking natural history of dog prostate cancer using DPC-1, a new canine prostate carcinoma cell line. Prostate 2001; 46 (1): 2-10.
11. LeRoy BE, Thudi NK, Nadella MV, Toribio RE, Tannehill-Gregg SH, van Bokhoven A, Davis D, Corn S, Rosol TJ,. New bone formation and osteolysis by a metastatic, highly invasive canine prostate carcinoma xenograft. Prostate 2006; 66 (11): 1213-1222. (Pubitemid 44175343)
12. Thudi NK, Shu ST, Martin CK, Lanigan LG, Nadella MV, Van Bokhoven A, Werbeck JL, Simmons JK, Murahari S, Kisseberth WC, Breen M, Williams C, Chen CS, McCauley LK, Keller ET, Rosol TJ,. Development of a brain metastatic canine prostate cancer cell line. Prostate 2011; 71 (12): 1251-1263.
13. Bezuidenhout AJ,. The Lymphatic System. In:, Evans HE, editor. Miller's anatomy of the dog. Chapter 13, 3rd edition. Philadelphia, London, Toronto, Montreal, Sydney, Tokyo: WB Saunders Company; 2000. pp. 744-755.
14. Chevalier S, Anidjar M, Scarlata E, Hamel L, Scherz A, Ficheux H, Borenstein N, Fiette L, Elhilali M,. Preclinical study of the novel vascular occluding agent, WST11, for photodynamic therapy of the canine prostate. J Urol 2011; 186 (1): 302-309.
15. Davies ET, Benson JA, Bicknell SR, Gray DE, Hewitt SG, Lloyd MK, Morisson JRA, Osler DC, Pepin GA, Purvis GM,. Manual of veterinary investigation laboratory techniques. 3rd edition. London: HM Stationary Office; 1984. pp. 6-7.
16. Shah RB, Mehra R, Chinnaiyan AM, Shen R, Ghosh D, Zhou M, Macvicar GR, Varambally S, Harwood J, Bismar TA, Kim R, Rubin MA, Pienta KJ,. Androgen-independent prostate cancer is a heterogeneous group of diseases: Lessons from a rapid autopsy program. Cancer Res 2004; 64 (24): 9209-9216. (Pubitemid 39665537)
17. Ahrar K, Madoff DC, Gupta S, Wallace MJ, Price RE, Wright KC,. Development of a large animal model for lung tumors. J Vasc Interv Radiol 2002; 13 (9 Pt 1): 923-928.
18. Deeg HJ, Hackman RC, Weiden PL, Storb R,. Growth of canine tumors transplanted into normal adult dogs immunosppressed by cyclosporin A. Cancer Immunol Immunother 1982; 12: 147-152. (Pubitemid 12192028)
19. Lai CL, van den Ham R, Mol J, Teske E,. Immunostaining of the androgen receptor and sequence analysis of its DNA-binding domain in canine prostate cancer. Vet J 2009; 181 (3): 256-260.
20. Bell FW, Klausner JS, Hayden DW, Feeney DA, Johnston SD,. Clinical and pathologic features of prostatic adenocarcinoma in sexually intact and castrated dogs: 31 cases (1970-1987). J Am Vet Med Assoc 1991; 199 (11): 1623-1630.
21. Ptachcinski RJ, Venkataramanan R, Burckart GJ, Gray JA, Van Thiel DH, Sanghvi A, Rosenthal JT,. Cyclosporine kinetics in healthy volunteers. J Clin Pharmacol 1987; 27 (3): 243-248. (Pubitemid 18026910)
22. Mundy GR,. Metastasis to bone: Causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002; 2 (8): 584-593. (Pubitemid 37328925)
23. Mehra R, Kumar-Sinha C, Shankar S, Lonigro RJ, Jing X, Philips NE, Siddiqui J, Han B, Cao X, Smith DC, Shah RB, Chinnaiyan AM, Pienta KJ,. Characterization of bone metastases from rapid autopsies of prostate cancer patients. Clin Cancer Res 2011; 17 (12): 3924-3932.